bretylium tosylate has been researched along with Diabetes Mellitus, Type 2 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Basu, A; Charkoudian, N; Fealey, RD; Roberts, SK; Sandroni, P; Sletten, D; Wick, DE | 1 |
1 other study(ies) available for bretylium tosylate and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Delayed threshold for active cutaneous vasodilation in patients with Type 2 diabetes mellitus.
Topics: Adrenergic Antagonists; Body Temperature; Body Temperature Regulation; Bretylium Tosylate; Diabetes Mellitus, Type 2; Hot Temperature; Humans; Laser-Doppler Flowmetry; Middle Aged; Regional Blood Flow; Skin; Sympathetic Nervous System; Vasodilation | 2006 |